Framework agreement for successive supply of selected medicines to Andalusian Health Service healthcare centres

Summary

The tender concerns a framework agreement with several companies for the successive supply of selected medicines at unit prices to healthcare centres of the Andalusian Health Service. The medicines include, among others, abacavir, abemaciclib, aflibercept, amoxicillin, apremilast, aripiprazole, avelumab, carfilzomib, ceftazidime, ceftriaxone, colistin, daratumumab, dasatinib and denosumab in various strengths and dosage forms. The planned contract duration is 24 months. The notice states a tax-exclusive amount of EUR 247,005,866.90 and an estimated overall amount of EUR 543,412,907.18. The tender submission deadline is 30 September 2026.